Precision NextGen Oncology — Beverly Hills, California

Precision NextGen Oncology is a clinical research site located in Beverly Hills, California, United States 90212.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Precision NextGen Oncology has participated in 11 clinical trials with 9 currently active.

Therapeutic areas: Liposarcoma, Dedifferentiated, Neoplasms, Tenosynovial Giant Cell Tumor.

Sponsors: Boehringer Ingelheim, Abbisko Therapeutics Co, Ltd, Krystal Biotech, Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Precision NextGen Oncology?

Precision NextGen Oncology has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Precision NextGen Oncology conducted?

Precision NextGen Oncology has 11 clinical trials on record, with 9 currently active. Their work covers Liposarcoma, Dedifferentiated, Neoplasms, Tenosynovial Giant Cell Tumor.

Is Precision NextGen Oncology accredited by Crixeo Health?

Yes — Precision NextGen Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Precision NextGen Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.